Fig. 8

Schematic showing that AGMAT inhibits SFRP2 + CAF infiltration to increase the therapeutic sensitivity to oxaliplatin
Schematic showing that AGMAT inhibits SFRP2 + CAF infiltration to increase the therapeutic sensitivity to oxaliplatin